SCHEMBL4237227

SCHEMBL4237227

CN(CCN1CCOCC1)c1ccc(Nc2ncc(C3CC3)c([AsH]CCCN)n2)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 6/20 0.44
AURKA O14965 5/20 0.44
CCNB1 P14635 5/20 0.44
NTSR1 P30989 2/20 0.40
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
LRRK2 Q5S007 3/20 0.37
TBK1 Q9UHD2 5/20 0.37
IGF1R P08069 1/20 0.37
SMYD3 Q9H7B4 1/20 0.36
IKBKE Q14164 3/20 0.35
MARK3 P27448 3/20 0.35
CDK2 P24941 1/20 0.35
BRSK2 Q8IWQ3 1/20 0.35
AURKB Q96GD4 1/20 0.35
MKNK1 Q9BUB5 1/20 0.35
NTRK1 P04629 1/20 0.35
ULK1 O75385 2/20 0.34
ULK2 Q8IYT8 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4237223 0.89 AURKA (0.44) CDK1AURKACCNB1NTSR1CYP3A4
SCHEMBL3387648 0.85 TBK1 (0.50) CDK1AURKACCNB1TBK1IKBKE
SCHEMBL3387635 0.77 TBK1 (0.50) CDK1AURKACCNB1TBK1SMYD3
SCHEMBL13431853 0.74 TBK1 (0.71) TBK1IKBKEMARK3CDK2BRSK2
SCHEMBL3385888 0.70 TBK1 (0.49) TBK1STK17A
SCHEMBL3389016 0.69 TBK1 (0.53) TBK1IGF1RIKBKEMARK3CDK2
SCHEMBL3384168 0.69 TBK1 (0.62) TBK1IKBKEMARK3CDK2BRSK2
SCHEMBL3386128 0.68 TBK1 (0.52) TBK1IGF1RIKBKEMARK3CDK2
SCHEMBL3388981 0.66 SMYD3 (0.42) NTSR1CYP3A4CYP2C19SMYD3
SCHEMBL3383970 0.65 TBK1 (0.72) TBK1IGF1RIKBKEMARK3CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009122180-A1 PYRIMIDINE DERIVATIVES CAPABLE OF INHIBITING ONE OR MORE KINASES MEDICAL RESEARCH COUNCIL (GB) 2009-10-08 WO disclosed